| CLBCX | FFAMX | CLBCX / FFAMX | |
| Total Expense Ratio | 1.35 | 0.82 | 165% |
| Annual Report Gross Expense Ratio | 1.35 | 0.85 | 159% |
| Fund Existence | 24 years | 20 years | - |
| Gain YTD | 8.985 | 8.672 | 104% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 288B | 10.9B | 2,642% |
| Annual Yield % from dividends | 1.07 | 1.90 | 56% |
| Returns for 1 year | 11.70 | 10.51 | 111% |
| Returns for 3 years | 39.43 | 33.23 | 119% |
| Returns for 5 years | 30.78 | 16.79 | 183% |
| Returns for 10 years | 80.22 | 61.25 | 131% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HFAFX | 18.07 | 0.14 | +0.78% |
| Hartford Schroders Intl Cntrrn Val R5 | |||
| GLBIX | 10.76 | 0.04 | +0.37% |
| Leuthold Global Institutional | |||
| BRWVX | 30.04 | 0.11 | +0.37% |
| MFS Blended Research Growth Eq R6 | |||
| MIDHX | 34.07 | 0.12 | +0.35% |
| MFS International New Discovery R3 | |||
| LGOAX | 54.25 | 0.06 | +0.11% |
| Patient Opportunity A | |||